MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-26-2026
Teladoc Health General and Administrative Expenses 2011-2026 | TDOC
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Teladoc Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 432 M | 435 M | 465 M | 450 M | 438 M | 507 M | 164 M | 119 M | 81.3 M | 52.7 M | 54.8 M | 19.6 M | 8.77 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 507 M | 8.77 M | 248 M |
Quarterly General and Administrative Expenses Teladoc Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 108 M | 113 M | - | 114 M | 110 M | 112 M | - | 116 M | 126 M | 114 M | - | 112 M | 113 M | 105 M | - | 103 M | 111 M | 105 M | - | 59.7 M | 56.6 M | 46.3 M | 44.5 M | 38.7 M | 38.5 M | 36 M | 36.5 M | 30.3 M | 26.1 M | 24 M | 27.5 M | 21.9 M | 15.9 M | 14.5 M | 13.4 M | 12.3 M | 11.3 M | 11.6 M | - | 10.1 M | 10.4 M | 12 M | - | 4.75 M | 4.03 M | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 126 M | 4.03 M | 57.1 M |
General and Administrative Expenses of other stocks in the Health information services industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
31.6 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
521 M | - | - | $ 27.9 B | USA |
 |
Computer Programs and Systems
CPSI
|
76.2 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
881 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
687 M | - | - | $ 9.03 B | USA |
 |
Castlight Health, Inc.
CSLT
|
25.7 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
123 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
217 M | - | - | $ 6.37 B | USA |
 |
iCAD
ICAD
|
7.63 M | - | - | $ 102 M | USA |
 |
Evolent Health
EVH
|
269 M | $ 2.53 | 8.58 % | $ 237 M | USA |
 |
GoodRx Holdings
GDRX
|
118 M | $ 2.15 | -1.83 % | $ 829 M | USA |
 |
Akerna Corp.
KERN
|
33.4 M | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
314 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
18.4 M | - | -0.58 % | $ 51.7 M | USA |
 |
NextGen Healthcare
NXGN
|
181 M | - | - | $ 1.6 B | USA |
 |
1Life Healthcare
ONEM
|
323 M | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
776 K | $ 5.93 | -3.26 % | $ 102 M | USA |
 |
Health Catalyst
HCAT
|
49.6 M | $ 1.06 | 6.39 % | $ 74.1 M | USA |
 |
HealthEquity
HQY
|
120 M | $ 79.91 | 2.5 % | $ 6.88 B | USA |
 |
Premier
PINC
|
701 M | - | - | $ 2.33 B | USA |
 |
Schrödinger
SDGR
|
95.4 M | $ 11.45 | 0.7 % | $ 841 M | USA |
 |
Phreesia
PHR
|
79.9 M | $ 8.56 | 6.2 % | $ 511 M | USA |
 |
R1 RCM
RCM
|
120 M | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
343 M | $ 23.58 | 1.33 % | $ 2.76 B | USA |
 |
Signify Health
SGFY
|
202 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
11.7 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
62.5 M | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
853 K | $ 1.06 | -30.72 % | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
88 M | $ 5.55 | 6.12 % | $ 89.1 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
75 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
35.1 M | $ 20.37 | 2.46 % | $ 619 M | USA |
 |
Omnicell
OMCL
|
380 M | $ 35.01 | 1.77 % | $ 1.61 B | USA |
 |
Progyny
PGNY
|
32 M | $ 16.98 | 4.17 % | $ 1.46 B | USA |
 |
So-Young International
SY
|
252 M | $ 2.69 | 4.26 % | $ 214 M |  China |
 |
Veeva Systems
VEEV
|
301 M | $ 158.45 | 4.66 % | $ 25.9 B | USA |
 |
Zhongchao
ZCMD
|
9.81 M | $ 2.01 | 1.01 % | $ 6.87 M | China |